At least four activist investors held stakes in Kenvue (KVUE) and D.E. Shaw, one of the Tylenol-maker’s largest shareholders, stood to suffer some of the biggest losses with a stake of around 3%, people familiar with the matter told The Wall Street Journal’s Ben Dummett and Lauren Thomas. However, because of Kimberly-Clark’s (KMB) buyout offer, the activist investor is set to break even on its investment, the sources said. Toms Capital Investment Management is another big shareholder in Kenvue with a more than 3% stake and Toms plans to keep holding its Kenvue shares after Monday’s deal, some of the sources said. Other activist investors exposed to Kenvue include Starboard Value and Dan Loeb’s Third Point, the WSJ noted.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- Early notable gainers among liquid option names on November 3rd
- Morning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
- Kimberly-Clark says ‘carefully considered’ risks, opportunities in Kenvue deal
- M&A: Diaper Group Kimberly-Clark Leaks 15% After $48.7B Purchase of Tylenol Maker Kenvue
- Kenvue Merges with Kimberly-Clark in $48.7B Deal